Simplex Trading’s MaxCyte MXCT Stock Holding History

Simplex Trading’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585	Sell	476 -791	-62%	-$788	﹤0.01%	8928
2026 Q1	$890	Buy	+1,267	New	+$1.18K	﹤0.01%	8624
2025 Q3	–	Sell	-100	Closed	-$174	–	9687
2025 Q2	$0	Buy	+100	New	+$242	﹤0.01%	9358
2024 Q4	–	Sell	-3,499	Closed	-$13.2K	–	9225
2024 Q3	$13K	Buy	3,499 +1,873	+115%	+$7.89K	﹤0.01%	7011
2024 Q2	$6K	Buy	1,626 +814	+100%	+$3.5K	﹤0.01%	7778
2024 Q1	$3K	Sell	812 -1,515	-65%	-$7.11K	﹤0.01%	8276
2023 Q4	$10K	Buy	2,327 +1,757	+308%	+$6.84K	﹤0.01%	7435
2023 Q3	$1K	Buy	570 +55	+11%	+$221	﹤0.01%	8367
2023 Q2	$2K	Buy	+515	New	+$2.37K	﹤0.01%	8456
2023 Q1	–	Sell	-1,018	Closed	-$5.01K	–	9746
2022 Q4	$5K	Buy	+1,018	New	+$6.24K	﹤0.01%	8074

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Simplex Trading's MXCT Position: Q2 2026 in Review

Simplex Trading reduced its MaxCyte (MXCT) stake by 62% in Q2 2026, selling an estimated $788 and leaving 476 shares worth $585. The position accounts for ﹤0.01% of the portfolio, ranked #8928.

Simplex Trading first reported a position in MXCT in Q4 2022 and has held it in 10 quarters since. The position peaked at $13K in Q3 2024. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Simplex Trading held 476 shares of MaxCyte worth $585 as of Q2 2026.
Simplex Trading sold 791 MaxCyte shares in Q2 2026, an estimated $788.
MaxCyte made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8928 holding.
Simplex Trading first reported a position in MaxCyte in Q4 2022 and has held it in 10 quarters since.
Simplex Trading's MaxCyte position peaked at $13K in Q3 2024.
122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.